Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of ATN-103 when administered
to subjects with active rheumatoid arthritis compared with placebo. All subjects must be on a
stable dose and route of methotrexate.